搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Gloeobacter violaceus Glucose-6-phosphate isomerase (pgi), partial CSB-YP766300GCI
CSB-EP766300GCI
CSB-BP766300GCI
CSB-MP766300GCI
CSB-EP766300GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus 50S ribosomal protein L10 (rplJ) CSB-YP766301GCI
CSB-EP766301GCI
CSB-BP766301GCI
CSB-MP766301GCI
CSB-EP766301GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP766302GCI
CSB-EP766302GCI
CSB-BP766302GCI
CSB-MP766302GCI
CSB-EP766302GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Elongation factor P (efp) CSB-YP766303GCI
CSB-EP766303GCI
CSB-BP766303GCI
CSB-MP766303GCI
CSB-EP766303GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Putative Holliday junction resolvase (gll1132) CSB-YP766304GCI
CSB-EP766304GCI
CSB-BP766304GCI
CSB-MP766304GCI
CSB-EP766304GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus UPF0145 protein gll1048 (gll1048) CSB-YP766305GCI
CSB-EP766305GCI
CSB-BP766305GCI
CSB-MP766305GCI
CSB-EP766305GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Probable phosphoketolase (glr0997), partial CSB-YP766306GCI
CSB-EP766306GCI
CSB-BP766306GCI
CSB-MP766306GCI
CSB-EP766306GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP766307GCI
CSB-EP766307GCI
CSB-BP766307GCI
CSB-MP766307GCI
CSB-EP766307GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus 50S ribosomal protein L19 (rplS) CSB-YP766308GCI
CSB-EP766308GCI
CSB-BP766308GCI
CSB-MP766308GCI
CSB-EP766308GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP766309GCI
CSB-EP766309GCI
CSB-BP766309GCI
CSB-MP766309GCI
CSB-EP766309GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP766310GCI
CSB-EP766310GCI
CSB-BP766310GCI
CSB-MP766310GCI
CSB-EP766310GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Thymidylate kinase (tmk) CSB-YP766311GCI
CSB-EP766311GCI
CSB-BP766311GCI
CSB-MP766311GCI
CSB-EP766311GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus UPF0272 protein gll0542 (gll0542) CSB-YP766312GCI
CSB-EP766312GCI
CSB-BP766312GCI
CSB-MP766312GCI
CSB-EP766312GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Bifunctional protein GlmU (glmU) CSB-YP766313GCI
CSB-EP766313GCI
CSB-BP766313GCI
CSB-MP766313GCI
CSB-EP766313GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Thiamine-phosphate synthase (thiE) CSB-YP766314GCI
CSB-EP766314GCI
CSB-BP766314GCI
CSB-MP766314GCI
CSB-EP766314GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Light-independent protochlorophyllide reductase subunit B (chlB), partial CSB-YP766315GCI
CSB-EP766315GCI
CSB-BP766315GCI
CSB-MP766315GCI
CSB-EP766315GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP766316GCI
CSB-EP766316GCI
CSB-BP766316GCI
CSB-MP766316GCI
CSB-EP766316GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gloeobacter violaceus Glutamate-1-semialdehyde 2,1-aminomutase (hemL) CSB-YP766317GCI
CSB-EP766317GCI
CSB-BP766317GCI
CSB-MP766317GCI
CSB-EP766317GCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Ribonuclease HII (rnhB) CSB-YP766318CKA
CSB-EP766318CKA
CSB-BP766318CKA
CSB-MP766318CKA
CSB-EP766318CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chromobacterium violaceum Pimelyl-[acyl-carrier protein] methyl ester esterase (bioH) CSB-YP766319CKA
CSB-EP766319CKA
CSB-BP766319CKA
CSB-MP766319CKA
CSB-EP766319CKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>